Immunohaematology – Eurofins Biomnis
Immunohaematology plays a critical role in the prevention of transfusion incidents, as well as the diagnosis and monitoring of fetal-maternal incompatibilities.

The following analyses are performed at Eurofins Biomnis:

  • blood typing ABO-RH-KEL1, extended phenotyping (systems FY, JK, MNS, LE, LU, etc.),
  • screening and identification of red cell antibodies,
  • the direct antiglobulin test,
  • titration and microtitration of anti-RH1 antibodies for the screening of a potential anti-RH1 immunisation in pregnant women after they received an injection of anti-D gamma globulins. Eurofins Biomnis collaborates with the CNRHP (Centre National de Référence en Hémobiologie Périnatale; National Centre of Reference in Perinatal Haemobiology) to monitor alloimmunised patients (titration, weighted assays for antibodies), and with the INTS (Institut National de la Transfusion Sanguine; National Institute of Blood Transfusion) for the diagnosis and monitoring of anti-platelet alloimmunizations.
  • research and quantification of fetal-maternal haemorrhage by flow cytometry. This technique is more reliable than the Kleihauer test and it measures with precision the percentage of fetal erythrocytes in the maternal circulation.

Biomnis Expert


Contact by email

Mettez à jour votre navigateur pour consulter ce site

Mettez à jour votre navigateur pour consulter ce site